NEW YORK, Sept. 22, 2010 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) (“NeoStem” or the “Company”), an international biopharmaceutical company with operations in the U.S. and China, today announced that its CEO, Robin L. Smith, MD, will present live at the NASDAQ MarketSite in Times Square, New York City a strategic development update.
